Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 836

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 836
---
:-------------|------------:|:----|:-------|--:|:----|:-----------|-------:|:----|:------------|:---------|:--|:----|:--------------|:--------|:--|
| Balance, December 31, 2023 |     |              | 160,000,000 |     | $      | 2 |     | $          | 72,598 |     | $           | (110,694 | ) |     | $             | (38,094 | ) |
| Net loss                   |     |              |           — |     |        | — |     |            |      — |     |             | (1,506   | ) |     |               | (1,506  | ) |
| Balance, March 31, 2024    |     |              | 160,000,000 |     | $      | 2 |     | $          | 72,598 |     | $           | (112,200 | ) |     | $             | (39,600 | ) |

See accompanying notes to unaudited condensed financial statements F-87

#### SEMNUR PHARMACEUTICALS, INC.CONDENSED STATEMENTS OF CASH FLOWS(In thousands)(Unaudited)Three Months EndedMarch 31,20252024Operating activitiesNet loss$(665)$(1,506)Adjustments to reconcile net loss to net cash used for operating activities:Stock-based compensation92179Changes in operating assets and liabilities:Prepaid expenses2(1)Accrued expenses172(831)Net cash used for operating activities(399)(2,159)Financing activitiesProceeds from related party loans1,2302,164Payments of deferred offering costs(836)—Net cash provided by financing activities3942,164Net change in cash and cash equivalents(5)5Cash and cash equivalents at beginning of period1212Cash and cash equivalents at end of period$7$17See accompanying notes to unaudited condensed financial statementsF-88
<div align='center'>**SEMNUR PHARMACEUTICALS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)**</div>

**Note 1. Nature of Operations and Basis of Presentation

Organization and Principal Activities

Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) was formed in 2013 and became a wholly owned subsidiary of